// company-profile
Fulcrum Therapeutics, Inc.
FULCExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings54Insiders20
// api This Fulcrum Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.
// activity-summary
No insider transactions in the last 30 days.
// 90-day insight
Over the last 90 days, Fulcrum Therapeutics, Inc. insiders bought $0 across 1 transaction with no open-market sales.
- Most active insider: Lehrer-Graiwer Joshua with 1 transaction totaling $0.
Activity skews bullish — buys outpace sales.
Institutional Ownership
Top 13F-HR holders of Fulcrum Therapeutics, Inc. as of 2026-03-31
Total reported AUM
$538.0M
QoQ change
-23.7%
Reporting period
2026-03-31
#1
SUVRETTA CAPITAL MANAGEMENT, LLC
CIK 1569064
$50.3M
6.6M shares
#2
RA CAPITAL MANAGEMENT, L.P.
CIK 1346824
$46.4M
6.1M shares
#3
TCG Crossover Management, LLC
CIK 1839948
$40.3M
5.3M shares
Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Apr 23, 2026 | Lehrer-Graiwer Joshua | FULC | Award | 64,000 | $0.00 | $0K |
| Feb 2, 2026 | Oltmans Curtis Gale | FULC | Award | 170,000 | $0.00 | $0K |
| Feb 2, 2026 | Sapir Alex | FULC | Award | 650,000 | $0.00 | $0K |
| Feb 2, 2026 | Gould Robert J | FULC | Sale10b5 | 15,000 | $10.72 | $161K |
| Feb 2, 2026 | Musso Alan A | FULC | Award | 170,000 | $0.00 | $0K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Popular companies on Form4API
Browse insider trading activity for other actively-filed companies.